Searched for
ZOMELIS
For risk takers: 5 midcap stocks that have moved from negative to neutral score can rise up to 22%As Nifty comes closer to form a new high, more number of mid-caps stocks are joining the party. Some stocks which had been trading earlier ...20 Jun, 2023, 11.40 AM IST- High ROE & net profit margin: 2 key elements of long-term wealth creatorsAs bulls make a comeback, many investors, especially the ones sitting on cash would be tempted to move back to the market. As one increases...29 Apr, 2023, 11.49 AM IST
- On a path to recovery; 5 mid-cap pharma stocks with an upside potential up to 41%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in bearish markets. Some of them are mid-sized Ind...22 Mar, 2023, 02.33 PM IST
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...02 Mar, 2023, 01.04 PM IST
- Eris Lifesciences scouting for acquisitions to diversify bizThrough acquisition of Strides domestic formulations portfolio in 2017, Eris Lifesciences got a toehold in the neurology and psychiatry seg...25 Aug, 2022, 12.43 AM IST
- Portugal to tax crypto, fixing legal loopholePortugal is one of the few countries in Europe where cryptocurrencies transactions are not taxable.20 May, 2022, 11.11 AM IST
- Eris acquires Oaknet Healthcare for Rs 650 crore to gain foothold in derma segmentThe drug maker said the acquisition will be completed by way of a share purchase agreement as a result of which Oaknet will become a wholly...04 May, 2022, 01.17 PM IST
- Eris Lifesciences Q4 Results: Net profit rises 17% to Rs 80 croreOn the outlook, Eris Lifesciences said it has an exciting pipeline of 'patent expiration' opportunities coming up in the cardiometabolic se...03 May, 2022, 03.17 PM IST
- USV in talks with Novartis to buy Jalra Trademark for Rs. 200 CroreMumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...09 Dec, 2019, 07.27 AM IST
- Citigroup maintains buy on Eris Lifesciences, raises target price to Rs 750The brokerage has raised FY21 and FY22 estimated EPS by 2.5% and 3% respectively.06 Dec, 2019, 08.28 AM IST
- Stocks in the news: YES Bank, Reliance Ind, Bharti Airtel, Gati, M&M and Allcargo LogisticsAntique Stock Broking has maintained buy rating on ICICI Bank with a target price of Rs 575.06 Dec, 2019, 08.10 AM IST
- Analyst Calls: Ambuja Cements,SpiceJet, ICICI Bank, Essel PropackIIFL has maintained reduce rating on Ambuja Cements with a target price of Rs 198.06 Dec, 2019, 07.26 AM IST
- UP drafting logistics policy, incentives includedThe policy will envisage the setting up of at least five industrial parks across the state, the smallest one with an investment of Rs 200 c...06 Jan, 2018, 12.00 AM IST
- Anti-diabetic drug cartel issue reaches CCI, Health MinistryCCI had been informed about the cartelisation allegations in a letter dated Feb 27, ET reported earlier. At that time, Novartis had denied ...24 Mar, 2017, 01.20 AM IST
- NPPA to look into diabetes drug price-fixing allegationsVildagliptin is a proprietary drug of Novartis sold under the brand Galvus and comes under a new class of anti-diabetic drugs known as DPP ...01 Mar, 2017, 01.32 AM IST
- 'WiMax the best for internet access'Xhom’s president Barry West spoke to ET on the regulatory scenario in India and the impact WiMax can have in the country:22 Nov, 2008, 02.35 AM IST
- Sprint Nextel to offer WiMax consultancySprint Nextel plans to set up a management company to offer WiMax consultancy services to op-erators in India and other countries to tap th...19 Nov, 2008, 01.14 AM IST
Load More
